Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Growth factor receptor-bound protein 2 (GRB2) is an adaptor protein that plays a crucial role in signal transduction. It consists of one SH2 domain and two SH3 domains, enabling it to link activated receptor tyrosine kinases (RTKs) to downstream signaling pathways. GRB2 primarily mediates the activation of Ras by recruiting SOS following growth factor stimulation and is involved in multiple cellular processes, including proliferation, differentiation, survival, and immune function. Altered GRB2 expression or function is implicated in cancer and immunological defects.
Inhibition of Grb2 interaction with its binding partners (e.g., SOS, EGFR) to disrupt downstream signaling pathways (e.g., Ras/MAPK).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Growth Factor Receptor-Bound Protein 2 (Grb2).